A study has raised concerns about the long-term effectiveness of certain weight loss drugs, such as Ozempic. It appears that people taking these drugs, known as GLP-1 weight loss drugs, may be moving less. The specifics of the study's findings and their implications are unclear, as reports on the topic are mixed and also touch on unrelated health issues.